BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37890653)

  • 1. Harnessing Precision Medicine: HLA or Eplet Matching in Heart Transplantation.
    Defilippis EM; Lacelle C; Garg S; Farr M
    J Card Fail; 2024 Feb; 30(2):373-375. PubMed ID: 37890653
    [No Abstract]   [Full Text] [Related]  

  • 2. Eplet matching in pediatric heart transplantation: The SickKids experience.
    Cardoso B; Wang J; Kiernan J; Dipchand AI
    J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heart transplantation for treatment of heart failure].
    Fukushima N
    Nihon Rinsho; 2007 May; 65 Suppl 5():243-8. PubMed ID: 17571390
    [No Abstract]   [Full Text] [Related]  

  • 5. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
    Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
    Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
    Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward donor allocation equitability for high immunological risk patients awaiting transplantation: "4S 4 HI-cPRA".
    West LJ
    Can J Cardiol; 2011; 27(6):677-8. PubMed ID: 22118018
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic Biomarkers for Precision Medicine in Heart Transplant: Is Galectin-3 the One?
    Grupper A; Pereira NL
    Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):889-891. PubMed ID: 31201105
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
    Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
    Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eplet incompatibility in pediatric renal transplantation.
    Rãchişan AL; Dubois V; Ranchin B; Sellier-Leclerc AL; Bertholet Thomas A; Cochat P; Bacchetta J
    Pediatr Transplant; 2020 Sep; 24(6):e13721. PubMed ID: 32388894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation.
    Tafulo S; Malheiro J; Santos S; Dias L; Almeida M; Martins S; Pedroso S; Mendes C; Lobato L; Castro-Henriques A
    Hum Immunol; 2019 Dec; 80(12):966-975. PubMed ID: 31604581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac transplantation--the next decade.
    Large SR
    Br J Hosp Med; 1995 May 3-16; 53(9):440-6. PubMed ID: 7613716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A successful 4S heart transplantation.
    Al-Mohaissen MA; Ignaszewski AP; Cheung A; Kaan A; Chiu W; Kealy J; Virani SA
    Can J Cardiol; 2011; 27(6):679-81. PubMed ID: 21944275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the art: cardiac transplantation.
    Davis MK; Hunt SA
    Trends Cardiovasc Med; 2014 Nov; 24(8):341-9. PubMed ID: 25258115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
    Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
    J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers.
    Bona M; Wyss RK; Arnold M; Méndez-Carmona N; Sanz MN; Günsch D; Barile L; Carrel TP; Longnus SL
    J Am Heart Assoc; 2021 Feb; 10(4):e018966. PubMed ID: 33522248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients.
    Charnaya O; Jones J; Philogene MC; Chiang PY; Segev DL; Massie AB; Garonzik-Wang J
    Pediatr Nephrol; 2021 Dec; 36(12):3971-3979. PubMed ID: 34100108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transplantation: a review.
    Yeatman M; Smith JA; Dunning JJ; Large SR; Wallwork J
    Cardiovasc Surg; 1995 Feb; 3(1):1-14. PubMed ID: 7780701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histocompatibility Assessment in Precision Medicine for Transplantation: Towards a Better Match.
    Yeung MY
    Semin Nephrol; 2022 Jan; 42(1):44-62. PubMed ID: 35618395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of human leukocyte antigen donor-recipient matching and pediatric heart transplant graft survival.
    Butts RJ; Scheurer MA; Atz AM; Moussa O; Burnette AL; Hulsey TC; Savage AJ
    Circ Heart Fail; 2014 Jul; 7(4):605-11. PubMed ID: 24833649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.